247 related articles for article (PubMed ID: 33420503)
1. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
Cooray S; Omyinmi E; Hong Y; Papadopoulou C; Harper L; Al-Abadi E; Goel R; Dubey S; Wood M; Jolles S; Berg S; Ekelund M; Armon K; Eleftheriou D; Brogan PA
Rheumatology (Oxford); 2021 Sep; 60(9):4373-4378. PubMed ID: 33420503
[TBL] [Abstract][Full Text] [Related]
2. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).
Clarke K; Campbell C; Omoyinmi E; Hong Y; Al Obaidi M; Sebire N; Brogan PA
Pediatr Rheumatol Online J; 2019 Jul; 17(1):39. PubMed ID: 31291964
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India.
Sharma A; Naidu G; Sharma V; Jha S; Dhooria A; Dhir V; Bhatia P; Sharma V; Bhattad S; Chengappa KG; Gupta V; Misra DP; Chavan PP; Malaviya S; Dudam R; Sharma B; Kumar S; Bhojwani R; Gupta P; Agarwal V; Sharma K; Singhal M; Rathi M; Nada R; Minz RW; Chaturvedi V; Aggarwal A; Handa R; Grossi A; Gattorno M; Huang Z; Wang J; Jois R; Negi VS; Khubchandani R; Jain S; Arostegui JI; Chambers EP; Hershfield MS; Aksentijevich I; Zhou Q; Lee PY
Arthritis Rheumatol; 2021 Feb; 73(2):276-285. PubMed ID: 32892503
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
[TBL] [Abstract][Full Text] [Related]
5. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Sahin S; Adrovic A; Barut K; Ugurlu S; Turanli ET; Ozdogan H; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):129-136. PubMed ID: 28516235
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
7. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G
Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2.
Keino D; Kondoh K; Kim Y; Sudo A; Ohyama R; Morimoto M; Nihira H; Izawa K; Iwaki-Egawa S; Mori T; Kinoshita A
Scand J Rheumatol; 2021 May; 50(3):243-245. PubMed ID: 32720851
[No Abstract] [Full Text] [Related]
10. Lentiviral Mediated
Hong Y; Casimir M; Houghton BC; Zhang F; Jensen B; Omoyinmi E; Torrance R; Papadopoulou C; Cummins M; Roderick M; Thrasher AJ; Brogan PA; Eleftheriou D
Front Immunol; 2022; 13():852830. PubMed ID: 35529868
[TBL] [Abstract][Full Text] [Related]
11. TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2).
Deuitch NT; Yang D; Lee PY; Yu X; Moura NS; Schnappauf O; Ombrello AK; Stone D; Kuehn HS; Rosenzweig SD; Hoffmann P; Cudrici C; Levy DM; Kessler E; Soep JB; Hay AD; Dalrymple A; Zhang Y; Sun L; Zhang Q; Tang X; Wu Y; Rao K; Li H; Luo H; Zhang Y; Burnham JM; Boehm M; Barron K; Kastner DL; Aksentijevich I; Zhou Q
J Allergy Clin Immunol; 2022 May; 149(5):1812-1816.e6. PubMed ID: 34780847
[TBL] [Abstract][Full Text] [Related]
12. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
[TBL] [Abstract][Full Text] [Related]
14. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
[TBL] [Abstract][Full Text] [Related]
16. Early onset is an indication of the severity of DADA2 disease.
Zhao X; Zhang J; Li C; Kuang W; Deng J; Tan X; Li C; Li S; Wang J
Rheumatology (Oxford); 2023 Feb; 62(2):969-976. PubMed ID: 35471231
[TBL] [Abstract][Full Text] [Related]
17. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
18. ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype.
Ferriani MPL; Valera ET; de Sousa GR; Sandrin-Garcia P; de Moura RR; Hershfield MS; de Carvalho LM
Rheumatology (Oxford); 2021 Jul; 60(7):e237-e239. PubMed ID: 33493352
[No Abstract] [Full Text] [Related]
19. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
[TBL] [Abstract][Full Text] [Related]
20. Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell RNA sequencing of monocytes.
Watanabe N; Gao S; Wu Z; Batchu S; Kajigaya S; Diamond C; Alemu L; Raffo DQ; Hoffmann P; Stone D; Ombrello AK; Young NS
J Leukoc Biol; 2021 Sep; 110(3):409-424. PubMed ID: 33988272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
